Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Fulgent Genetics, Inc. (FLGT) had Income from Continuous Operations of $-23.65M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$83.34M |
|
$-23.42M |
|
$50.75M |
|
$32.58M |
|
$119.57M |
|
$-36.24M |
|
$6.96M |
|
$-29.27M |
|
$-29.27M |
|
$-23.65M |
|
|
Income from Continuous Operations |
$-23.65M |
$-23.65M |
|
$-23.50M |
|
$-36.24M |
|
$-40.99M |
|
30.78M |
|
30.78M |
|
$-0.77 |
|
$-0.77 |
|
| Balance Sheet Financials | |
$550.49M |
|
$112.55M |
|
$663.03M |
|
$1.21B |
|
$84.97M |
|
-- |
|
$21.84M |
|
$106.81M |
|
$1.11B |
|
$1.02B |
|
$1.11B |
|
31.08M |
|
| Cash Flow Statement Financials | |
$-101.64M |
|
$111.37M |
|
$-14.79M |
|
$55.28M |
|
$50.33M |
|
$-4.95M |
|
$39.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.48 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
39.10% |
|
-43.48% |
|
-43.48% |
|
-- |
|
-35.13% |
|
-28.10% |
|
$-124.21M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
0.98 |
|
91.54 |
|
-2.14% |
|
-2.33% |
|
-1.95% |
|
-2.14% |
|
$35.61 |
|
$-4.04 |
|
$-3.30 |
|